Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Markers of Kidney Tubular Secretion and Risk of Acute Kidney Injury after Acute Heart Failure.

Kidney360·2026
Same author

Markers of kidney tubule dysfunction and injury and long-term risk of acute kidney injury following coronary artery bypass graft surgery.

PloS one·2026
Same author

Estradiol protects kidney tubules against ferroptosis.

Kidney international·2026
Same author

Current evidence and future directions for KIM-1 as a blood-based biomarker in RCC.

Nature reviews. Clinical oncology·2026
Same author

Implementing virtual reality for emergency training in nephrology: a large-scale study on educational impact and acceptance.

Clinical kidney journal·2026
Same author

National Institutes of Health Workshop to Accelerate Therapeutic Innovation by Optimizing Kidney Precision Medicine Clinical Trials.

Clinical journal of the American Society of Nephrology : CJASN·2026

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
07:22

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids

Published on: September 1, 2023

4.0K

Regenerating the nephron with human pluripotent stem cells.

Albert Q Lam1, Joseph V Bonventre

  • 1aDivision of Kidney Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston bHarvard Stem Cell Institute, Cambridge, Massachusetts, USA.

Current Opinion in Organ Transplantation
|February 20, 2015
PubMed
Summary

Human pluripotent stem cells (PSCs) show promise for regenerating kidney tissue by differentiating into nephron progenitor cells (NPCs). This research advances potential therapies for kidney disease by creating nephron-like structures in vitro.

More Related Videos

A Simplified Method for Generating Kidney Organoids from Human Pluripotent Stem Cells
07:39

A Simplified Method for Generating Kidney Organoids from Human Pluripotent Stem Cells

Published on: April 13, 2021

7.0K
Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
10:23

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Published on: November 4, 2022

3.7K

Related Experiment Videos

Last Updated: Apr 17, 2026

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids
07:22

Author Spotlight: Optimizing iPSC Differentiation for Efficient Production to Generate Kidney Organoids

Published on: September 1, 2023

4.0K
A Simplified Method for Generating Kidney Organoids from Human Pluripotent Stem Cells
07:39

A Simplified Method for Generating Kidney Organoids from Human Pluripotent Stem Cells

Published on: April 13, 2021

7.0K
Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells
10:23

Isogenic Kidney Glomerulus Chip Engineered from Human Induced Pluripotent Stem Cells

Published on: November 4, 2022

3.7K

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Nephrology

Background:

  • Human nephrogenesis concludes before birth, with no new nephron formation postnatally.
  • Kidney injury leads to irreversible nephron loss and impaired function.
  • Human pluripotent stem cells (PSCs) offer a potential source for regenerating kidney tissue.

Purpose of the Study:

  • To explore the potential of human PSCs for generating nephron progenitor cells (NPCs).
  • To advance therapeutic strategies for kidney disease through stem cell-based regeneration.

Main Methods:

  • Directing human PSC differentiation towards NPCs.
  • Recapitulating kidney organogenesis in vitro to generate NPC markers.
  • Assembling cells into three-dimensional nephron-like structures.

Main Results:

  • Significant progress in differentiating human PSCs into NPCs.
  • Generated cells express characteristic NPC markers.
  • Cells self-assembled into three-dimensional nephron-like structures in vitro.

Conclusions:

  • Successful recreation of human nephrons from PSCs could offer novel therapeutic approaches for kidney disease.
  • Further research is needed to assess cell functionality and integration into organized kidney tissue.